9 reviews for 2026 Update in Urologic Oncology

1. Julian Foster

   Rated 4 out of 5

   This is a thorough course for professionals who need an updated overview of genitourinary cancer care. The range of faculty and subject areas provides...More

   This is a thorough course for professionals who need an updated overview of genitourinary cancer care. The range of faculty and subject areas provides useful exposure to different treatment perspectives, including urologic surgery, medical oncology, radiation oncology, imaging, genomics, and supportive care. I valued the practical focus on real decision points such as prostate biopsy, active surveillance, radical cystectomy, robotic renal surgery, cytoreductive nephrectomy, and systemic therapy selection. The course is detailed and may contain more material than every learner needs, but the session-based structure makes selective viewing straightforward. I would rate it highly for content breadth, though navigation and concise take-home summaries are important when working through such a large program.

   Helpful? 0 0
   Claire Donovan

   Rated 5 out of 5

   The course addresses many of the practical questions that arise when managing patients with GU malignancies, including when to use surveillance, how t...More

   The course addresses many of the practical questions that arise when managing patients with GU malignancies, including when to use surveillance, how to interpret risk information, and how to sequence local and systemic treatments. I found the sessions on prostate cancer recurrence, advanced RCC, bladder preservation, and hereditary renal cancer particularly informative. The curriculum also recognizes that good oncology care includes recovery, survivorship, sexual function, frailty, and communication around palliative needs. The presentation is comprehensive, although the amount of content means that it works better as an ongoing learning resource than a single-sitting course. A few more concise end-of-module summaries would improve usability, but the overall structure and clinical scope are strong.

   Helpful? 0 0
   Nathan Brooks

   Rated 5 out of 5

   I used the course as a structured update rather than watching every session in one sequence. That worked well because the curriculum is divided into c...More

   I used the course as a structured update rather than watching every session in one sequence. That worked well because the curriculum is divided into clear disease-focused topics. The prostate cancer content is especially substantial, but there is also strong coverage of bladder, upper-tract urothelial, renal, germ-cell, and penile cancers. The lectures on survivorship, adverse effects, sexual health, and palliative care add important context beyond tumor-directed treatment. My main criticism is that the volume of material can feel overwhelming at first, and a recommended viewing pathway for different specialties would be helpful. Still, the depth is beneficial for learners who want more than a short review. Overall, it is a solid educational course with broad clinical relevance.

   Helpful? 0 0
   Grace Ellison

   Rated 5 out of 5

   This program is useful for clinicians who want one place to review the major developments affecting urologic oncology practice. The strongest feature ...More

   This program is useful for clinicians who want one place to review the major developments affecting urologic oncology practice. The strongest feature for me was the integration of diagnostic information with treatment planning. Imaging, genomic classifiers, biomarkers, surgical options, radiation, and systemic therapies are presented as connected parts of patient management rather than isolated topics. I also liked the inclusion of less commonly covered areas such as pediatric urologic oncology, adrenal masses, frailty assessments, smoking cessation, and artificial intelligence. The course is quite extensive, so some learners may prefer to focus first on their main disease areas. Even so, the modular format supports that approach. It is a detailed and practical resource, particularly for multidisciplinary teams.

   Helpful? 0 0
   Ethan Caldwell

   Rated 5 out of 5

   The course provides a broad review of GU oncology and is especially helpful for identifying knowledge gaps across multiple disease sites. I found the ...More

   The course provides a broad review of GU oncology and is especially helpful for identifying knowledge gaps across multiple disease sites. I found the bladder cancer section clear and comprehensive, with coverage of hematuria evaluation, NMIBC risk stratification, neoadjuvant and adjuvant therapy, cystectomy, and trimodality treatment. The renal cancer sessions also offer a useful mix of imaging, surgical, radiation, hereditary, and systemic therapy topics. Because the program includes many lectures, it is not a quick overview and may require planning to complete. However, the detailed curriculum makes it useful as both a learning course and a reference source. I would have liked a little more summary material between modules, but the clinical breadth and organization remain valuable.

   Helpful? 0 0
   Olivia Hartwell

   Rated 5 out of 5

   I appreciated that the course balances evidence updates with practical clinical topics. The sessions on current screening controversies, genomic risk ...More

   I appreciated that the course balances evidence updates with practical clinical topics. The sessions on current screening controversies, genomic risk tools, advanced imaging, robotic techniques, systemic therapy, and bladder-preservation pathways provide a strong overview of how the field is evolving. The faculty perspectives also make the course feel multidisciplinary rather than limited to a single treatment modality. Another strength is the attention given to survivorship and quality-of-life issues, including sexual health and treatment-related adverse effects. Some lectures are naturally more relevant to specific specialties than others, but the breadth allows learners to select the sections most useful to their practice. In my view, this is a strong option for anyone seeking a structured 2026 review of genitourinary oncology.

   Helpful? 0 0
   Michael Rowan

   Rated 5 out of 5

   This course helped me review several areas that are difficult to keep current through journal reading alone. The prostate cancer modules cover screeni...More

   This course helped me review several areas that are difficult to keep current through journal reading alone. The prostate cancer modules cover screening, biopsy, surveillance, surgery, radiation, recurrence, and advanced disease, while the bladder and kidney sections address both surgical and systemic approaches. I especially liked the emphasis on treatment sequencing and multidisciplinary coordination because those are often the areas where clinical decisions become most complex. The inclusion of survivorship, sexual health, enhanced recovery, frailty, and end-of-life care also gives the program a broader patient-centered perspective. The course requires a meaningful time commitment, but the on-demand structure makes it manageable. It is a useful educational resource for clinicians who want a comprehensive rather than superficial GU oncology update.

   Helpful? 0 0
   Samantha Vale

   Rated 5 out of 5

   What stood out to me was the range of topics included in one course. It moves beyond the most common prostate cancer discussions and also covers bladd...More

   What stood out to me was the range of topics included in one course. It moves beyond the most common prostate cancer discussions and also covers bladder cancer, kidney cancer, germ-cell tumors, penile cancer, adrenal lesions, survivorship, frailty, and palliative care. The sessions on imaging, biomarkers, genomics, and multidisciplinary planning help connect newer evidence with practical treatment decisions. I found the course particularly valuable as a reference because each topic is presented separately and can be revisited without searching through unrelated content. The material is detailed, so it may feel extensive for someone seeking only a brief summary, but that depth is also its main strength. Overall, it provides a well-rounded update for professionals involved in GU cancer care.

   Helpful? 0 0
   Daniel Mercer

   Rated 5 out of 5

   The course is organized in a way that makes a large and rapidly changing field easier to review. I found the sections on prostate cancer risk stratifi...More

   The course is organized in a way that makes a large and rapidly changing field easier to review. I found the sections on prostate cancer risk stratification, genomic classifiers, radiation options, and advanced systemic therapy especially useful. The progression from diagnosis through treatment and survivorship made the material feel connected rather than fragmented. I also appreciated the coverage of bladder preservation, renal mass imaging, and treatment sequencing across specialties. For a clinician looking for a structured overview of current genitourinary oncology topics, the curriculum offers a broad and clinically oriented learning experience. The large number of sessions means it is best approached gradually, but the modular format makes it easy to return to specific disease areas when needed.

   Helpful? 0 0